Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist (Sanofi)
Diabetes News Service
Sanofi portfolio expands to offer first once-a-day prandial GLP-1 receptor agonist (Sanofi)
For iPhone and iPad | For Android devices
For information about sponsorship and advertising please contact our editor-in-chief Jim Young jim@glycosmedia.com
Website by Wired up Wales